NDAINJECTIONINJECTABLE
Approved
Aug 1971
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
NAVANE (thiothixene hydrochloride) by Pfizer is actions thiothixene is an antipsychotic of the thioxanthene series. First approved in 1971.
Drug data last refreshed 27m ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NAVANE (thiothixene hydrochloride) is an injectable antipsychotic of the thioxanthene class, approved in 1971 for treatment of schizophrenia and other psychotic disorders. It works by blocking dopamine receptors in the central nervous system, similar to phenothiazine antipsychotics. The drug is administered via intramuscular injection and represents a legacy antipsychotic option in a crowded market.
LOE Approaching
As a legacy injectable antipsychotic approaching loss of exclusivity, NAVANE likely operates as a maintenance product with minimal team expansion and reduced commercial investment.
Mechanism of Action
ACTIONS Thiothixene is an antipsychotic of the thioxanthene series. Thiothixene possesses certain chemical and pharmacological similarities to the piperazine phenothiazines and differences from the aliphatic group of phenothiazines.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
NAVANE offers limited career growth opportunities; the product is in LOE Approaching stage with zero linked job count and minimal commercial investment. Positions on this team are typically maintenance-focused, emphasizing managed care relationships, payer negotiations, and patient access programs rather than growth-oriented brand building.
Brand Manager
Worked on NAVANE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.